regeneron semaglutide pharmaceuticals announced on January 30, 2026, that its experimental obesity drug candidate delivers significant cholesterol-lowering benefits on top of weight loss—a differentiation strategy aimed at competing with Eli Lilly's and Regeneron's weight-loss drug combo helps

When Lower BMI Patients Might Benefit From GLP-1 Therapy People with lower BMIs may pursue GLP-1 medications for legitimate reasons beyond traditional weight loss: managing binge eating disorder, reducing visceral fat while preserving muscle with proper nutrition, improving metabolic health markers like insulin resistance or blood sugar variability, or addressing food noise and compulsive eating patterns

Some plans cover FDA-approved medications such as Wegovy or Zepbound, often requiring prior authorization

Clinical data shows that 70% of patients with initial headaches experience relief by week three without further intervention

As a co-founder and the CEO of Artisight, he is at the forefront of fusing deep learning and IoT sensors to facilitate healthcare automation and optimization

Ingredients like CoQ10 and vitamin C are commonly included in skincare products for their ability to brighten the complexion and protect against premature aging